Showing 1 - 20 results of 24 for search 'Paolo Gaibani', query time: 0.06s Refine Results
  1. 1
    Genomic characterization of a high pathogenic Escherichia coli causing bacterial meningitis in a newborn in Italy, 2022

    Genomic characterization of a high pathogenic Escherichia coli causing bacterial meningitis in a newborn in Italy, 2022 by Prof Paolo Gaibani

    Published 2025-03-01
    Get full text
    Article
  2. 2
    Prophages in Bacteroides fragilis: Distribution and genetic diversity

    Prophages in Bacteroides fragilis: Distribution and genetic diversity by Paolo Gaibani, Rocco Latorre

    Published 2025-02-01
    Get full text
    Article
  3. 3
    Comparison of Broth Microdilution, Disk Diffusion and Strip Test Methods for Cefiderocol Antimicrobial Susceptibility Testing on KPC-Producing <i>Klebsiella pneumoniae</i>

    Comparison of Broth Microdilution, Disk Diffusion and Strip Test Methods for Cefiderocol Antimicrobial Susceptibility Testing on KPC-Producing <i>Klebsiella pneumoniae</i> by Federica Bovo, Tiziana Lazzarotto, Simone Ambretti, Paolo Gaibani

    Published 2023-03-01
    Get full text
    Article
  4. 4
    Complete genome sequence and antimicrobial resistance analysis of ESBL-producing Shigella sonnei carrying small cryptic plasmids isolated in northern Italy

    Complete genome sequence and antimicrobial resistance analysis of ESBL-producing Shigella sonnei carrying small cryptic plasmids isolated in northern Italy by Stefano Amadesi, Simone Ambretti, Tiziana Lazzarotto, Paolo Gaibani

    Published 2023-06-01
    Get full text
    Article
  5. 5
    Synergistic Activity of Cefiderocol in Combination with Piperacillin-Tazobactam, Fosfomycin, Ampicillin-Sulbactam, Imipenem-Relebactam and Ceftazidime-Avibactam against Carbapenem-Resistant Gram-Negative Bacteria

    Synergistic Activity of Cefiderocol in Combination with Piperacillin-Tazobactam, Fosfomycin, Ampicillin-Sulbactam, Imipenem-Relebactam and Ceftazidime-Avibactam against Carbapenem-... by Marta Palombo, Federica Bovo, Stefano Amadesi, Paolo Gaibani

    Published 2023-05-01
    Get full text
    Article
  6. 6
    Colistin: Lights and Shadows of an Older Antibiotic

    Colistin: Lights and Shadows of an Older Antibiotic by Erica Diani, Gabriele Bianco, Milo Gatti, Davide Gibellini, Paolo Gaibani

    Published 2024-06-01
    Get full text
    Article
  7. 7
    Epidemiology and In Vitro Activity of Ceftazidime/Avibactam, Meropenem/Vaborbactam and Imipenem/Relebactam against <i>KPC</i>-Producing <i>K. pneumoniae</i> Collected from Bacteremic Patients, 2018 to 2020

    Epidemiology and In Vitro Activity of Ceftazidime/Avibactam, Meropenem/Vaborbactam and Imipenem/Relebactam against <i>KPC</i>-Producing <i>K. pneumoniae</i> Collected from Bacterem... by Federica Bovo, Donatella Lombardo, Tiziana Lazzarotto, Simone Ambretti, Paolo Gaibani

    Published 2022-11-01
    Get full text
    Article
  8. 8
    In Vitro Evaluation of Increasing Avibactam Concentrations on Ceftazidime Activity against Ceftazidime/Avibactam-Susceptible and Resistant KPC-Producing <i>Klebsiella pneumoniae</i> Clinical Isolates

    In Vitro Evaluation of Increasing Avibactam Concentrations on Ceftazidime Activity against Ceftazidime/Avibactam-Susceptible and Resistant KPC-Producing <i>Klebsiella pneumoniae</i... by Marta Palombo, Benedetta Secci, Federica Bovo, Milo Gatti, Simone Ambretti, Paolo Gaibani

    Published 2023-12-01
    Get full text
    Article
  9. 9
    Pharmacokinetic/pharmacodynamic target attainment of continuous infusion ceftazidime-avibactam in peritoneal fluid in an orthotopic liver transplant recipient affected by bacteraemic complicated intra-abdominal infection due to OXA-181-producing Klebsiella pneumoniae

    Pharmacokinetic/pharmacodynamic target attainment of continuous infusion ceftazidime-avibactam in peritoneal fluid in an orthotopic liver transplant recipient affected by bacteraem... by Milo Gatti, Matteo Rinaldi, Paolo Gaibani, Antonio Siniscalchi, Pierluigi Viale, Federico Pea

    Published 2023-09-01
    Get full text
    Article
  10. 10
    Pharmacokinetic/Pharmacodynamic Analysis of Continuous-Infusion Fosfomycin in Combination with Extended-Infusion Cefiderocol or Continuous-Infusion Ceftazidime-Avibactam in a Case Series of Difficult-to-Treat Resistant <i>Pseudomonas aeruginosa</i> Bloodstream Infections and/or Hospital-Acquired Pneumonia

    Pharmacokinetic/Pharmacodynamic Analysis of Continuous-Infusion Fosfomycin in Combination with Extended-Infusion Cefiderocol or Continuous-Infusion Ceftazidime-Avibactam in a Case... by Milo Gatti, Maddalena Giannella, Matteo Rinaldi, Paolo Gaibani, Pierluigi Viale, Federico Pea

    Published 2022-12-01
    Get full text
    Article
  11. 11
    Synergistic Activity of Cefiderocol in Combination with Avibactam, Sulbactam or Tazobactam against Carbapenem-Resistant Gram-Negative Bacteria

    Synergistic Activity of Cefiderocol in Combination with Avibactam, Sulbactam or Tazobactam against Carbapenem-Resistant Gram-Negative Bacteria by Russell E. Lewis, Marta Palombo, Erica Diani, Benedetta Secci, Davide Gibellini, Paolo Gaibani

    Published 2024-08-01
    Get full text
    Article
  12. 12
    Dengue and falciparum malaria co-infection in travelers returning from Burkina Faso: Report of two cases in Northeastern Italy

    Dengue and falciparum malaria co-infection in travelers returning from Burkina Faso: Report of two cases in Northeastern Italy by Antonio Mastroianni, Caterina Vocale, Vittorio Sambri, Tiziana Lazzarotto, Paolo Gaibani, Giada Rossini, Stefania Varani

    Published 2023-01-01
    Get full text
    Article
  13. 13
    Complete Genome Sequence of a <i>Klebsiella pneumoniae</i> Strain Carrying Novel Variant <i>bla</i><sub>KPC-203</sub>, Cross-Resistant to Ceftazidime/Avibactam and Cefiderocol, but Susceptible to Carbapenems, Isolated in Italy, 2023

    Complete Genome Sequence of a <i>Klebsiella pneumoniae</i> Strain Carrying Novel Variant <i>bla</i><sub>KPC-203</sub>, Cross-Resistant to Ceftazidime/Avibactam and Cefiderocol, but... by Stefano Amadesi, Gabriele Bianco, Benedetta Secci, Teresa Fasciana, Matteo Boattini, Cristina Costa, Paolo Gaibani

    Published 2024-06-01
    Get full text
    Article
  14. 14
    Whole Genome Sequencing of a <i>Chlamydia trachomatis</i> Strain Responsible for a Case of Rectal Lymphogranuloma Venereum in Italy

    Whole Genome Sequencing of a <i>Chlamydia trachomatis</i> Strain Responsible for a Case of Rectal Lymphogranuloma Venereum in Italy by Antonella Marangoni, Stefano Amadesi, Marielle Ezekielle Djusse, Claudio Foschi, Valeria Gaspari, Tiziana Lazzarotto, Paolo Gaibani

    Published 2023-02-01
    Get full text
    Article
  15. 15
    Synergistic Effect of Clinically Available Beta-Lactamase Inhibitors Combined with Cefiderocol against Carbapenemase-Producing Gram-Negative Organisms

    Synergistic Effect of Clinically Available Beta-Lactamase Inhibitors Combined with Cefiderocol against Carbapenemase-Producing Gram-Negative Organisms by Gabriele Bianco, Paolo Gaibani, Sara Comini, Matteo Boattini, Giuliana Banche, Cristina Costa, Rossana Cavallo, Patrice Nordmann

    Published 2022-11-01
    Get full text
    Article
  16. 16
    Epidemiology and Genetic Traits of Carbapenemase-Producing Enterobacterales: A Global Threat to Human Health

    Epidemiology and Genetic Traits of Carbapenemase-Producing Enterobacterales: A Global Threat to Human Health by Gualtiero Alvisi, Antonio Curtoni, Rossella Fonnesu, Aurora Piazza, Caterina Signoretto, Giorgia Piccinini, Davide Sassera, Paolo Gaibani

    Published 2025-02-01
    Get full text
    Article
  17. 17
    Successful Treatment of Bloodstream Infection due to a KPC-Producing Klebsiella Pneumoniae Resistant to Imipenem/Relebactam in a Hematological Patient

    Successful Treatment of Bloodstream Infection due to a KPC-Producing Klebsiella Pneumoniae Resistant to Imipenem/Relebactam in a Hematological Patient by Paolo Gaibani, Linda Bussini, Stefano Amadesi, Michele Bartoletti, Federica Bovo, Tiziana Lazzarotto, Pierluigi Viale, Simone Ambretti

    Published 2022-04-01
    Get full text
    Article
  18. 18
    Successful Treatment of Bacteremia and Ventilator-Associated Pneumonia Caused by KPC/OXA-48-like <i>Klebsiella pneumoniae</i> Co-Producer with a Continuous Infusion of High-Dose Meropenem Plus Fosfomycin Guided by Real-Time Therapeutic Drug Monitoring

    Successful Treatment of Bacteremia and Ventilator-Associated Pneumonia Caused by KPC/OXA-48-like <i>Klebsiella pneumoniae</i> Co-Producer with a Continuous Infusion of High-Dose Me... by Pier Giorgio Cojutti, Giacomo Fornaro, Milo Gatti, Matteo Rinaldi, Paolo Gaibani, Maddalena Giannella, Federico Pea, Pierluigi Viale

    Published 2022-01-01
    Get full text
    Article
  19. 19
    Real-Time Optimization of Pharmacodynamic Target Attainment at Infection Site during Treatment of Post-Neurosurgical Ventriculitis Caused by Carbapenem-Resistant Gram Negatives with Ceftazidime–Avibactam-Based Regimens: A Report of Two Cases

    Real-Time Optimization of Pharmacodynamic Target Attainment at Infection Site during Treatment of Post-Neurosurgical Ventriculitis Caused by Carbapenem-Resistant Gram Negatives wit... by Milo Gatti, Giulio Virgili, Pier Giorgio Cojutti, Paolo Gaibani, Matteo Conti, Carmelo Sturiale, Federico Pea, Pierluigi Viale

    Published 2022-01-01
    Get full text
    Article
  20. 20
    Resistance to Ceftazidime/Avibactam, Meropenem/Vaborbactam and Imipenem/Relebactam in Gram-Negative MDR Bacilli: Molecular Mechanisms and Susceptibility Testing

    Resistance to Ceftazidime/Avibactam, Meropenem/Vaborbactam and Imipenem/Relebactam in Gram-Negative MDR Bacilli: Molecular Mechanisms and Susceptibility Testing by Paolo Gaibani, Tommaso Giani, Federica Bovo, Donatella Lombardo, Stefano Amadesi, Tiziana Lazzarotto, Marco Coppi, Gian Maria Rossolini, Simone Ambretti

    Published 2022-05-01
    Get full text
    Article

Search Tools: